Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen

Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood imm...

Full description

Saved in:
Bibliographic Details
Published inNature immunology Vol. 19; no. 6; pp. 617 - 624
Main Authors Rollenske, Tim, Szijarto, Valeria, Lukasiewicz, Jolanta, Guachalla, Luis M., Stojkovic, Katarina, Hartl, Katharina, Stulik, Lukas, Kocher, Simone, Lasitschka, Felix, Al-Saeedi, Mohammed, Schröder-Braunstein, Jutta, von Frankenberg, Moritz, Gaebelein, Gereon, Hoffmann, Peter, Klein, Sabrina, Heeg, Klaus, Nagy, Eszter, Nagy, Gabor, Wardemann, Hedda
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.06.2018
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M–positive (IgM + ) and IgA + memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae , an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae , as K. pneumonia e–specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non– K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies. Carbohydrate-specific antibodies are typically thought to be of low affinity and produced by T cell–independent pathways. Wardemann and colleagues identify human memory B cells that can produce specific ‘affinity-matured’ antibodies to the O antigen of Klebsiella lipopolysaccharides.
AbstractList Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM+) and IgA+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM+) and IgA+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.
Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM ) and IgA memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.
Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M–positive (IgM+) and IgA+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae–specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non–K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.
Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM.sup.+) and IgA.sup.+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies. Carbohydrate-specific antibodies are typically thought to be of low affinity and produced by T cell-independent pathways. Wardemann and colleagues identify human memory B cells that can produce specific 'affinity-matured' antibodies to the O antigen of Klebsiella lipopolysaccharides.
Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM.sup.+) and IgA.sup.+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.
Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M–positive (IgM + ) and IgA + memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae , an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae , as K. pneumonia e–specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non– K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies. Carbohydrate-specific antibodies are typically thought to be of low affinity and produced by T cell–independent pathways. Wardemann and colleagues identify human memory B cells that can produce specific ‘affinity-matured’ antibodies to the O antigen of Klebsiella lipopolysaccharides.
Audience Academic
Author Klein, Sabrina
Hoffmann, Peter
Lukasiewicz, Jolanta
Stojkovic, Katarina
Kocher, Simone
von Frankenberg, Moritz
Hartl, Katharina
Heeg, Klaus
Nagy, Gabor
Lasitschka, Felix
Schröder-Braunstein, Jutta
Szijarto, Valeria
Gaebelein, Gereon
Al-Saeedi, Mohammed
Nagy, Eszter
Stulik, Lukas
Rollenske, Tim
Wardemann, Hedda
Guachalla, Luis M.
Author_xml – sequence: 1
  givenname: Tim
  surname: Rollenske
  fullname: Rollenske, Tim
  organization: Max Planck Research Group Molecular Immunology, Max Planck Institute for Infection Biology, Division of B Cell Immunology, German Cancer Research Center
– sequence: 2
  givenname: Valeria
  surname: Szijarto
  fullname: Szijarto, Valeria
  organization: Arsanis Biosciences
– sequence: 3
  givenname: Jolanta
  surname: Lukasiewicz
  fullname: Lukasiewicz, Jolanta
  organization: Department of Immunochemistry, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences
– sequence: 4
  givenname: Luis M.
  orcidid: 0000-0003-1152-9930
  surname: Guachalla
  fullname: Guachalla, Luis M.
  organization: Arsanis Biosciences
– sequence: 5
  givenname: Katarina
  surname: Stojkovic
  fullname: Stojkovic, Katarina
  organization: Department of Immunochemistry, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences
– sequence: 6
  givenname: Katharina
  surname: Hartl
  fullname: Hartl, Katharina
  organization: Arsanis Biosciences
– sequence: 7
  givenname: Lukas
  surname: Stulik
  fullname: Stulik, Lukas
  organization: Arsanis Biosciences
– sequence: 8
  givenname: Simone
  surname: Kocher
  fullname: Kocher, Simone
  organization: Division of B Cell Immunology, German Cancer Research Center
– sequence: 9
  givenname: Felix
  orcidid: 0000-0002-3212-1881
  surname: Lasitschka
  fullname: Lasitschka, Felix
  organization: Institute of Pathology, University Hospital Heidelberg
– sequence: 10
  givenname: Mohammed
  surname: Al-Saeedi
  fullname: Al-Saeedi, Mohammed
  organization: Department of General and Transplant Surgery, University Hospital Heidelberg
– sequence: 11
  givenname: Jutta
  surname: Schröder-Braunstein
  fullname: Schröder-Braunstein, Jutta
  organization: Institute of Immunology, University Hospital Heidelberg
– sequence: 12
  givenname: Moritz
  surname: von Frankenberg
  fullname: von Frankenberg, Moritz
  organization: Department of General, Abdominal and Minimal Invasive Surgery, Hospital Salem
– sequence: 13
  givenname: Gereon
  surname: Gaebelein
  fullname: Gaebelein, Gereon
  organization: Department of Visceral, Transplantation, Thoracic and Vascular Surgery, University Hospital Leipzig, Department of General, Visceral, Vascular and Pediatric Surgery, Saarland University Medical Center
– sequence: 14
  givenname: Peter
  surname: Hoffmann
  fullname: Hoffmann, Peter
  organization: Department of Gastroenterology, University Hospital Heidelberg
– sequence: 15
  givenname: Sabrina
  surname: Klein
  fullname: Klein, Sabrina
  organization: Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospital Heidelberg
– sequence: 16
  givenname: Klaus
  surname: Heeg
  fullname: Heeg, Klaus
  organization: Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospital Heidelberg
– sequence: 17
  givenname: Eszter
  surname: Nagy
  fullname: Nagy, Eszter
  organization: Arsanis Biosciences
– sequence: 18
  givenname: Gabor
  surname: Nagy
  fullname: Nagy, Gabor
  organization: Arsanis Biosciences
– sequence: 19
  givenname: Hedda
  orcidid: 0000-0003-3921-5933
  surname: Wardemann
  fullname: Wardemann, Hedda
  email: h.wardemann@dkfz.de
  organization: Max Planck Research Group Molecular Immunology, Max Planck Institute for Infection Biology, Division of B Cell Immunology, German Cancer Research Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29760533$$D View this record in MEDLINE/PubMed
BookMark eNp9kt1r1TAYxoNsuC__AG8k4I1edOajSZrLcZg6dmDi5p0Q0vZtzWjTY5KK--9NPXPjDJUQEsLvefMkz3uE9vzkAaGXlJxSwqt3saRCk4LQKk8iC_YMHVLBdME0lXsPe1IdoKMYbwmhpZLlc3TAtJJEcH6Ivq7CFGMRN9C4zjUu3eGpw5swJWiS-wH42zxaj61Prp5aBxHb3jofE74coI4OhsHijYd5nLyzgNefrvFVseA9-BO039khwov79Rh9eX9-s_pYrK8-XKzO1kUjuE6F4qUSkmqQXJO2VFprSksqK8VrC5Iw0VnOBas1p1xmoq00Y5y3gnb5RYwfozfbutn39xliMqOLzWLNwzRHwwjXrMplRUZfP0Fvpzn47C5TJVOsklo-Ur0dwDjfTSnYZilqzoRiQqjyN3X6FyqPFkbX5Kg6l893BG93BJlJ8DP1do7RXFx_3mVf3Rud6xFaswlutOHO_IkuA3QLNEuCAboHhBKztIfZtofJ7WGW9jDLR6knmpy4TS77CNYN_1WyrTLmW3wP4fHf_i36BXBxyL4
CitedBy_id crossref_primary_10_1039_D3OB01203D
crossref_primary_10_1128_IAI_00412_21
crossref_primary_10_1007_s00253_022_11989_w
crossref_primary_10_1128_mSphere_01335_20
crossref_primary_10_3390_vaccines10111789
crossref_primary_10_1172_JCI122032
crossref_primary_10_2147_IDR_S338987
crossref_primary_10_1084_jem_20200275
crossref_primary_10_1093_infdis_jiae097
crossref_primary_10_1016_j_carres_2023_108807
crossref_primary_10_1007_s00018_018_2976_8
crossref_primary_10_1038_s41385_019_0223_8
crossref_primary_10_1038_s41385_019_0227_4
crossref_primary_10_1038_s41586_021_03973_7
crossref_primary_10_1126_sciadv_ado9455
crossref_primary_10_1016_j_immuni_2023_08_018
crossref_primary_10_1146_annurev_immunol_042718_041238
crossref_primary_10_3389_fmolb_2021_719396
crossref_primary_10_1084_jem_20180977
crossref_primary_10_1038_s41385_018_0120_6
crossref_primary_10_1002_adfm_202001232
crossref_primary_10_1016_j_celrep_2019_03_032
crossref_primary_10_1016_j_jim_2020_112752
crossref_primary_10_1038_s41575_022_00674_y
crossref_primary_10_1097_BOR_0000000000000574
crossref_primary_10_1021_acscatal_0c05378
crossref_primary_10_1038_s41467_024_52372_9
crossref_primary_10_1039_C8LC01310A
crossref_primary_10_1016_j_vetmic_2022_109361
crossref_primary_10_1002_1873_3468_14347
crossref_primary_10_1097_QCO_0000000000000539
crossref_primary_10_3389_fimmu_2020_595535
crossref_primary_10_3389_fmicb_2022_880484
crossref_primary_10_3390_ijms25105487
crossref_primary_10_1093_intimm_dxab109
crossref_primary_10_2745_dds_37_395
crossref_primary_10_1093_intimm_dxab066
crossref_primary_10_1126_sciadv_abf6834
crossref_primary_10_1016_j_cell_2023_10_002
crossref_primary_10_1111_imr_13014
crossref_primary_10_1084_jem_20181635
crossref_primary_10_1371_journal_pmed_1004239
crossref_primary_10_15252_emmm_202115386
crossref_primary_10_1016_j_csbj_2019_09_011
crossref_primary_10_1016_j_carbpol_2023_121581
crossref_primary_10_1042_BCJ20200610
crossref_primary_10_1016_j_lanmic_2024_100988
crossref_primary_10_1093_pnasnexus_pgad310
crossref_primary_10_3390_ijms21186572
crossref_primary_10_1016_j_jaci_2018_09_036
crossref_primary_10_1021_acsabm_9b00936
crossref_primary_10_1128_mmbr_00045_22
crossref_primary_10_1038_s41385_022_00539_2
crossref_primary_10_1084_jem_20220839
crossref_primary_10_3390_vaccines12101177
crossref_primary_10_3390_ijms22084042
crossref_primary_10_1128_mmbr_00090_23
crossref_primary_10_1016_j_it_2024_01_006
crossref_primary_10_1038_s41590_020_00856_3
crossref_primary_10_1016_j_jbc_2024_107420
crossref_primary_10_1016_j_micres_2025_128083
crossref_primary_10_1080_14760584_2019_1635460
crossref_primary_10_1038_s41385_019_0192_y
crossref_primary_10_1242_dmm_043240
crossref_primary_10_1002_ejoc_201900389
crossref_primary_10_1371_journal_pone_0203143
crossref_primary_10_1126_sciimmunol_abc7191
crossref_primary_10_1126_sciimmunol_abg3208
crossref_primary_10_17816_MAJ633511
crossref_primary_10_3390_ijms22168896
crossref_primary_10_1128_spectrum_00400_24
crossref_primary_10_1038_s41598_023_39613_5
crossref_primary_10_3389_fimmu_2023_1193855
crossref_primary_10_3390_diagnostics13152490
crossref_primary_10_1016_j_celrep_2022_110611
crossref_primary_10_1016_j_mimet_2023_106730
crossref_primary_10_3389_fimmu_2020_573629
crossref_primary_10_1212_NXI_0000000000000997
crossref_primary_10_1099_mgen_0_000433
crossref_primary_10_3389_fimmu_2020_01755
crossref_primary_10_1038_s41577_019_0261_1
crossref_primary_10_3389_fmolb_2021_666756
crossref_primary_10_1038_s41564_024_01612_1
crossref_primary_10_1073_pnas_2301302120
crossref_primary_10_1016_j_coi_2019_09_003
crossref_primary_10_1016_j_mib_2020_08_003
crossref_primary_10_1016_j_immuni_2018_08_011
crossref_primary_10_1016_j_it_2023_08_005
crossref_primary_10_3389_fimmu_2018_03064
crossref_primary_10_1038_s41590_018_0216_x
crossref_primary_10_1038_s42003_021_02714_w
crossref_primary_10_3390_vaccines8010013
crossref_primary_10_1152_ajplung_00377_2023
crossref_primary_10_1038_s41589_020_0494_0
crossref_primary_10_1038_s41435_020_0105_9
crossref_primary_10_3389_fimmu_2024_1404192
crossref_primary_10_1080_19420862_2021_2006123
crossref_primary_10_1128_msphere_00680_22
crossref_primary_10_1126_scitranslmed_abl3927
Cites_doi 10.1172/JCI44447
10.1186/1471-2105-13-31
10.1038/35098100
10.1093/bioinformatics/btu393
10.1038/ni.3213
10.1002/eji.201545526
10.1016/S0264-410X(98)00139-X
10.1074/jbc.M202683200
10.1099/mgen.0.000073
10.1038/nmeth.f.303
10.1038/mi.2012.56
10.1126/science.1086907
10.1016/j.chom.2007.01.002
10.1038/nature07830
10.1016/j.jim.2007.09.017
10.3389/fmicb.2017.00684
10.1016/j.chom.2014.07.003
10.1099/00221287-12-2-367
10.1073/pnas.0700630104
10.1016/j.ijmm.2015.12.002
10.1038/nri.2016.114
10.1080/21505594.2017.1279778
10.1016/j.immuni.2015.06.013
10.1016/j.it.2015.06.006
10.1128/AAC.04494-14
10.1016/j.immuni.2017.06.013
10.1128/CMR.11.4.589
10.1007/s00281-004-0182-2
10.1016/j.chom.2007.09.013
10.1016/j.jim.2015.04.010
10.1016/j.immuni.2007.01.009
10.1111/febs.13530
10.1172/JCI91192
10.1186/s12859-016-0920-1
10.1084/jem.57.4.571
10.1084/jem.20161590
10.1128/jb.173.4.1420-1431.1991
10.1016/S0008-6215(00)90412-9
10.1146/annurev.iy.13.040195.003255
10.1084/jem.20011112
10.1126/science.aan6619
10.1007/978-0-387-98141-3
10.1084/jem.44.5.683
10.1038/s41598-017-06682-2
10.7883/yoken.JJID.2014.051
10.1084/jem.50.5.551
10.1128/JB.180.15.3735-3740.1998
10.1128/JCM.37.1.56-62.1999
10.1128/CDLI.4.5.550-555.1997
ContentType Journal Article
Copyright The Author(s) 2018
COPYRIGHT 2018 Nature Publishing Group
Copyright Nature Publishing Group Jun 2018
Copyright_xml – notice: The Author(s) 2018
– notice: COPYRIGHT 2018 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jun 2018
DBID AAYXX
CITATION
NPM
ISR
3V.
7QP
7QR
7T5
7TK
7TM
7U9
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
DOI 10.1038/s41590-018-0106-2
DatabaseName CrossRef
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Proquest Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Central Student
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Public Health
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
ProQuest Central Student




Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1529-2916
EndPage 624
ExternalDocumentID A572557496
29760533
10_1038_s41590_018_0106_2
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
0R~
123
29M
2FS
36B
39C
3V.
4.4
53G
5BI
5RE
70F
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8R4
8R5
AAEEF
AAHBH
AARCD
AAYZH
AAZLF
ABAWZ
ABDBF
ABJNI
ABLJU
ABNNU
ABOCM
ABUWG
ACBWK
ACGFS
ACIWK
ACPRK
ACRPL
ACUHS
ADBBV
ADNMO
AENEX
AEUYN
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGGDT
AGHTU
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
AIYXT
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ARMCB
ASPBG
AVWKF
AXYYD
AZFZN
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CCPQU
CS3
DB5
DU5
EAD
EAP
EAS
EBS
EE.
EJD
EMB
EMK
EMOBN
ESX
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
ISR
ITC
L-9
LK8
M1P
M7P
N9A
NNMJJ
O9-
ODYON
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNT
RNTTT
SHXYY
SIXXV
SNYQT
SOJ
SV3
TAOOD
TBHMF
TDRGL
TSG
TUS
UKHRP
WH7
X7M
Y6R
ZXP
AAYXX
AFANA
ALPWD
ATHPR
CITATION
PHGZM
PHGZT
NPM
PMFND
7QP
7QR
7T5
7TK
7TM
7U9
7XB
8FD
8FK
AZQEC
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
ID FETCH-LOGICAL-c539t-73475619e6390d4799911416873bae6025fa3352b931360d4d892233d51f14723
IEDL.DBID 7X7
ISSN 1529-2908
1529-2916
IngestDate Mon Jul 21 11:20:33 EDT 2025
Fri Jul 25 09:08:56 EDT 2025
Tue Jun 17 21:45:12 EDT 2025
Tue Jun 10 20:24:04 EDT 2025
Fri Jun 27 05:08:28 EDT 2025
Wed Feb 19 02:32:19 EST 2025
Thu Apr 24 22:54:04 EDT 2025
Tue Jul 01 03:07:11 EDT 2025
Fri Feb 21 02:38:57 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c539t-73475619e6390d4799911416873bae6025fa3352b931360d4d892233d51f14723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1152-9930
0000-0002-3212-1881
0000-0003-3921-5933
PMID 29760533
PQID 2042728696
PQPubID 45782
PageCount 8
ParticipantIDs proquest_miscellaneous_2039289995
proquest_journals_2042728696
gale_infotracmisc_A572557496
gale_infotracacademiconefile_A572557496
gale_incontextgauss_ISR_A572557496
pubmed_primary_29760533
crossref_primary_10_1038_s41590_018_0106_2
crossref_citationtrail_10_1038_s41590_018_0106_2
springer_journals_10_1038_s41590_018_0106_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-06-01
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Nature immunology
PublicationTitleAbbrev Nat Immunol
PublicationTitleAlternate Nat Immunol
PublicationYear 2018
Publisher Nature Publishing Group US
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group US
– name: Nature Publishing Group
References Tillett, Avery, Goebel (CR4) 1929; 50
Landsverk (CR32) 2017; 214
Tiller (CR38) 2008; 329
Trautmann (CR6) 1997; 4
Podschun, Ullmann (CR9) 1998; 11
Guachalla (CR18) 2017; 7
Zhou (CR25) 2007; 1
Baumgarth, Tung, Herzenberg (CR31) 2005; 26
Toellner (CR14) 2002; 195
Hansen (CR7) 1999; 37
Wickham (CR50) 2009
Tiller (CR36) 2007; 26
Szijártó (CR44) 2017; 8
Bunker (CR13) 2017; 358
Stojkovic (CR17) 2017; 8
Lorin, Mouquet (CR40) 2015; 422
CR47
Vinogradov (CR5) 2002; 277
Bergqvist (CR29) 2013; 6
Gu, Gu, Eils, Schlesner, Brors (CR51) 2014; 30
Cerca (CR43) 2007; 104
Mond, Lees, Snapper (CR11) 1995; 13
Lipke, Ovalle (CR21) 1998; 180
Julianelle (CR1) 1926; 44
Lindner (CR28) 2015; 16
Szijártó (CR42) 2015; 59
Polonskaya (CR26) 2017; 127
Masella, Bartram, Truszkowski, Brown, Neufeld (CR45) 2012; 13
Trama (CR23) 2014; 16
Fagarasan, Kinoshita, Muramatsu, Ikuta, Honjo (CR27) 2001; 413
Wardemann (CR41) 2003; 301
Whitfield, Richards, Perry, Clarke, MacLean (CR15) 1991; 173
Doores (CR22) 2015; 282
Bayhan, Senel, Tanir, Ozkan (CR24) 2015; 68
Caporaso (CR46) 2010; 7
Macpherson, Köller, McCoy (CR33) 2015; 36
Di Niro (CR30) 2015; 43
Murugan, Imkeller, Busse, Wardemann (CR39) 2015; 45
Szijártó (CR16) 2016; 306
Imkeller, Arndt, Wardemann, Busse (CR48) 2016; 17
Warnes (CR49) 2009; 2
Follador (CR8) 2016; 2
Magri (CR12) 2017; 47
Lancefield (CR2) 1933; 57
Coughlin (CR34) 1998; 16
Park (CR19) 2009; 458
Benckert (CR37) 2011; 121
Kubinak, Round (CR10) 2016; 16
Peterson, McNulty, Guruge, Gordon (CR35) 2007; 2
Shattock (CR3) 1955; 12
Jansson (CR20) 1985; 145
C Lindner (106_CR28) 2015; 16
R Follador (106_CR8) 2016; 2
R Murugan (106_CR39) 2015; 45
GI Bayhan (106_CR24) 2015; 68
PN Lipke (106_CR21) 1998; 180
T Tiller (106_CR38) 2008; 329
G Magri (106_CR12) 2017; 47
RT Coughlin (106_CR34) 1998; 16
R Niro Di (106_CR30) 2015; 43
KM Toellner (106_CR14) 2002; 195
S Fagarasan (106_CR27) 2001; 413
ZH Zhou (106_CR25) 2007; 1
H Wickham (106_CR50) 2009
K Stojkovic (106_CR17) 2017; 8
J Benckert (106_CR37) 2011; 121
M Trautmann (106_CR6) 1997; 4
AJ Macpherson (106_CR33) 2015; 36
OJB Landsverk (106_CR32) 2017; 214
KJ Doores (106_CR22) 2015; 282
V Szijártó (106_CR42) 2015; 59
JJ Mond (106_CR11) 1995; 13
AM Trama (106_CR23) 2014; 16
JG Caporaso (106_CR46) 2010; 7
AP Masella (106_CR45) 2012; 13
JJ Bunker (106_CR13) 2017; 358
106_CR47
Z Polonskaya (106_CR26) 2017; 127
N Baumgarth (106_CR31) 2005; 26
RC Lancefield (106_CR2) 1933; 57
V Szijártó (106_CR16) 2016; 306
JL Kubinak (106_CR10) 2016; 16
PE Jansson (106_CR20) 1985; 145
V Szijártó (106_CR44) 2017; 8
H Wardemann (106_CR41) 2003; 301
K Imkeller (106_CR48) 2016; 17
T Tiller (106_CR36) 2007; 26
DS Hansen (106_CR7) 1999; 37
WS Tillett (106_CR4) 1929; 50
LM Guachalla (106_CR18) 2017; 7
GR Warnes (106_CR49) 2009; 2
PMF Shattock (106_CR3) 1955; 12
Z Gu (106_CR51) 2014; 30
BS Park (106_CR19) 2009; 458
E Vinogradov (106_CR5) 2002; 277
C Whitfield (106_CR15) 1991; 173
V Lorin (106_CR40) 2015; 422
N Cerca (106_CR43) 2007; 104
P Bergqvist (106_CR29) 2013; 6
R Podschun (106_CR9) 1998; 11
LA Julianelle (106_CR1) 1926; 44
DA Peterson (106_CR35) 2007; 2
29777208 - Nat Immunol. 2018 Jun;19(6):514-515
References_xml – volume: 121
  start-page: 1946
  year: 2011
  end-page: 1955
  ident: CR37
  article-title: The majority of intestinal IgA and IgG plasmablasts in the human gut are antigen-specific
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI44447
– volume: 13
  year: 2012
  ident: CR45
  article-title: PANDAseq: paired-end assembler for illumina sequences
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-13-31
– volume: 413
  start-page: 639
  year: 2001
  end-page: 643
  ident: CR27
  article-title: In situ class switching and differentiation to IgA-producing cells in the gut lamina propria
  publication-title: Nature
  doi: 10.1038/35098100
– volume: 30
  start-page: 2811
  year: 2014
  end-page: 2812
  ident: CR51
  article-title: circlize Implements and enhances circular visualization in R
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu393
– volume: 16
  start-page: 880
  year: 2015
  end-page: 888
  ident: CR28
  article-title: Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3213
– volume: 45
  start-page: 2698
  year: 2015
  end-page: 2700
  ident: CR39
  article-title: Direct high-throughput amplification and sequencing of immunoglobulin genes from single human B cells
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201545526
– volume: 16
  start-page: 1761
  year: 1998
  end-page: 1767
  ident: CR34
  article-title: Characterization of pneumococcal specific antibodies in healthy unvaccinated adults
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(98)00139-X
– volume: 277
  start-page: 25070
  year: 2002
  end-page: 25081
  ident: CR5
  article-title: Structures of lipopolysaccharides from . Eluicidation of the structure of the linkage region between core and polysaccharide O chain and identification of the residues at the non-reducing termini of the O chains
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M202683200
– volume: 2
  start-page: e000073
  year: 2016
  ident: CR8
  article-title: The diversity of surface polysaccharides
  publication-title: Microb. Genomics
  doi: 10.1099/mgen.0.000073
– volume: 7
  start-page: 335
  year: 2010
  end-page: 336
  ident: CR46
  article-title: QIIME allows analysis of high-throughput community sequencing data
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.f.303
– volume: 6
  start-page: 122
  year: 2013
  end-page: 135
  ident: CR29
  article-title: Re-utilization of germinal centers in multiple Peyer’s patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses
  publication-title: Mucosal Immunol.
  doi: 10.1038/mi.2012.56
– volume: 301
  start-page: 1374
  year: 2003
  end-page: 1377
  ident: CR41
  article-title: Predominant autoantibody production by early human B cell precursors
  publication-title: Science
  doi: 10.1126/science.1086907
– volume: 1
  start-page: 51
  year: 2007
  end-page: 61
  ident: CR25
  article-title: The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2007.01.002
– volume: 458
  start-page: 1191
  year: 2009
  end-page: 1195
  ident: CR19
  article-title: The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
  publication-title: Nature
  doi: 10.1038/nature07830
– volume: 329
  start-page: 112
  year: 2008
  end-page: 124
  ident: CR38
  article-title: Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2007.09.017
– volume: 8
  start-page: 684
  year: 2017
  ident: CR17
  article-title: Identification of d-galactan-III as part of the lipopolysaccharide of Serotype O1
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2017.00684
– volume: 16
  start-page: 215
  year: 2014
  end-page: 226
  ident: CR23
  article-title: HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2014.07.003
– volume: 12
  start-page: 367
  year: 1955
  end-page: 374
  ident: CR3
  article-title: The use of serology in the classification of micro-organisms
  publication-title: J. Gen. Microbiol.
  doi: 10.1099/00221287-12-2-367
– volume: 104
  start-page: 7528
  year: 2007
  end-page: 7533
  ident: CR43
  article-title: Protection against infection by antibody to the poly-N-acetylglucosamine surface polysaccharide
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0700630104
– volume: 306
  start-page: 89
  year: 2016
  end-page: 98
  ident: CR16
  article-title: Both clades of the epidemic KPC-producing clone ST258 share a modified galactan O-antigen type
  publication-title: Int. J. Med. Microbiol.
  doi: 10.1016/j.ijmm.2015.12.002
– volume: 16
  start-page: 767
  year: 2016
  end-page: 774
  ident: CR10
  article-title: Do antibodies select a healthy microbiota?
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri.2016.114
– volume: 2
  start-page: 1
  year: 2009
  ident: CR49
  article-title: Various R programming tools for plotting data
  publication-title: R package version
– volume: 8
  start-page: 1203
  year: 2017
  end-page: 1215
  ident: CR44
  article-title: Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against ST258
  publication-title: Virulence
  doi: 10.1080/21505594.2017.1279778
– volume: 43
  start-page: 120
  year: 2015
  end-page: 131
  ident: CR30
  article-title: Salmonella infection drives promiscuous B cell activation followed by extrafollicular affinity maturation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.06.013
– volume: 36
  start-page: 460
  year: 2015
  end-page: 470
  ident: CR33
  article-title: The bilateral responsiveness between intestinal microbes and IgA
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2015.06.006
– volume: 59
  start-page: 3109
  year: 2015
  end-page: 3116
  ident: CR42
  article-title: Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant clone ST131-O25b:H4 elicit protection in mice
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.04494-14
– volume: 47
  start-page: 118
  year: 2017
  end-page: 134
  ident: CR12
  article-title: Human secretory IgM emerges from plasma cells clonally related to gut memory B cells and targets highly diverse commensals
  publication-title: Immunity
  doi: 10.1016/j.immuni.2017.06.013
– volume: 11
  start-page: 589
  year: 1998
  end-page: 603
  ident: CR9
  article-title: spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.11.4.589
– volume: 26
  start-page: 347
  year: 2005
  end-page: 362
  ident: CR31
  article-title: Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion
  publication-title: Springer Semin. Immunopathol.
  doi: 10.1007/s00281-004-0182-2
– volume: 2
  start-page: 328
  year: 2007
  end-page: 339
  ident: CR35
  article-title: IgA response to symbiotic bacteria as a mediator of gut homeostasis
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2007.09.013
– volume: 37
  start-page: 56
  year: 1999
  end-page: 62
  ident: CR7
  article-title: lipopolysaccharide O typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries
  publication-title: J. Clin. Microbiol.
– ident: CR47
– volume: 422
  start-page: 102
  year: 2015
  end-page: 110
  ident: CR40
  article-title: Efficient generation of human IgA monoclonal antibodies
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2015.04.010
– volume: 26
  start-page: 205
  year: 2007
  end-page: 213
  ident: CR36
  article-title: Autoreactivity in human IgG memory B cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2007.01.009
– volume: 282
  start-page: 4679
  year: 2015
  end-page: 4691
  ident: CR22
  article-title: The HIV glycan shield as a target for broadly neutralizing antibodies
  publication-title: FEBS J.
  doi: 10.1111/febs.13530
– volume: 127
  start-page: 1491
  year: 2017
  end-page: 1504
  ident: CR26
  article-title: T cells control the generation of nanomolar-affinity anti-glycan antibodies
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI91192
– volume: 17
  year: 2016
  ident: CR48
  article-title: sciReptor: analysis of single-cell level immunoglobulin repertoires
  publication-title: BMC Bioinformatics
  doi: 10.1186/s12859-016-0920-1
– volume: 57
  start-page: 571
  year: 1933
  end-page: 595
  ident: CR2
  article-title: A serological differentiation of human and other groups of hemolytic Streptococci
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.57.4.571
– volume: 214
  start-page: 309
  year: 2017
  end-page: 317
  ident: CR32
  article-title: Antibody-secreting plasma cells persist for decades in human intestine
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20161590
– volume: 173
  start-page: 1420
  year: 1991
  end-page: 1431
  ident: CR15
  article-title: Expression of two structurally distinct D-galactan O antigens in the lipopolysaccharide of serotype O1
  publication-title: J. Bacteriol.
  doi: 10.1128/jb.173.4.1420-1431.1991
– volume: 145
  start-page: 59
  year: 1985
  end-page: 66
  ident: CR20
  article-title: Structural studies of the O-antigen polysaccharides of Klebsiella O5 and O8
  publication-title: Carbohydr. Res.
  doi: 10.1016/S0008-6215(00)90412-9
– volume: 13
  start-page: 655
  year: 1995
  end-page: 692
  ident: CR11
  article-title: T cell-independent antigens type 2
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.iy.13.040195.003255
– volume: 195
  start-page: 383
  year: 2002
  end-page: 389
  ident: CR14
  article-title: Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20011112
– volume: 358
  start-page: eaan6619
  year: 2017
  ident: CR13
  article-title: Natural polyreactive IgA antibodies coat the intestinal microbiota
  publication-title: Science
  doi: 10.1126/science.aan6619
– year: 2009
  ident: CR50
  publication-title: ggplot2: Elegant Graphics for Data Analysis
  doi: 10.1007/978-0-387-98141-3
– volume: 44
  start-page: 683
  year: 1926
  end-page: 696
  ident: CR1
  article-title: Immunological relationships of encapsulated and capsule-free strains of encapsulated pneumoniae (Friedlander’s Bacillus)
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.44.5.683
– volume: 7
  year: 2017
  ident: CR18
  article-title: Discovery of monoclonal antibodies cross-reactive to novel subserotypes of K. pneumoniae O3
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-06682-2
– volume: 68
  start-page: 50
  year: 2015
  end-page: 54
  ident: CR24
  article-title: Bacteremia caused by in pediatric patients
  publication-title: Jpn. J. Infect. Dis.
  doi: 10.7883/yoken.JJID.2014.051
– volume: 180
  start-page: 3735
  year: 1998
  end-page: 3740
  ident: CR21
  article-title: Cell wall architecture in yeast: new structure and new challenges
  publication-title: J. Bacteriol.
– volume: 4
  start-page: 550
  year: 1997
  end-page: 555
  ident: CR6
  article-title: O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections
  publication-title: Clin. Diagn. Lab. Immunol.
– volume: 50
  start-page: 551
  year: 1929
  end-page: 567
  ident: CR4
  article-title: Chemo-immunological studies in conjugated carbohydrate-proteins: III. Active and passive anaphylaxis with synthetic sugar-proteins
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.50.5.551
– volume: 2
  start-page: e000073
  year: 2016
  ident: 106_CR8
  publication-title: Microb. Genomics
  doi: 10.1099/mgen.0.000073
– volume: 13
  start-page: 655
  year: 1995
  ident: 106_CR11
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.iy.13.040195.003255
– volume: 2
  start-page: 328
  year: 2007
  ident: 106_CR35
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2007.09.013
– volume: 59
  start-page: 3109
  year: 2015
  ident: 106_CR42
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.04494-14
– volume: 11
  start-page: 589
  year: 1998
  ident: 106_CR9
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.11.4.589
– volume: 277
  start-page: 25070
  year: 2002
  ident: 106_CR5
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M202683200
– volume: 358
  start-page: eaan6619
  year: 2017
  ident: 106_CR13
  publication-title: Science
  doi: 10.1126/science.aan6619
– ident: 106_CR47
– volume: 26
  start-page: 205
  year: 2007
  ident: 106_CR36
  publication-title: Immunity
  doi: 10.1016/j.immuni.2007.01.009
– volume: 26
  start-page: 347
  year: 2005
  ident: 106_CR31
  publication-title: Springer Semin. Immunopathol.
  doi: 10.1007/s00281-004-0182-2
– volume: 8
  start-page: 1203
  year: 2017
  ident: 106_CR44
  publication-title: Virulence
  doi: 10.1080/21505594.2017.1279778
– volume: 413
  start-page: 639
  year: 2001
  ident: 106_CR27
  publication-title: Nature
  doi: 10.1038/35098100
– volume: 173
  start-page: 1420
  year: 1991
  ident: 106_CR15
  publication-title: J. Bacteriol.
  doi: 10.1128/jb.173.4.1420-1431.1991
– volume: 301
  start-page: 1374
  year: 2003
  ident: 106_CR41
  publication-title: Science
  doi: 10.1126/science.1086907
– volume: 50
  start-page: 551
  year: 1929
  ident: 106_CR4
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.50.5.551
– volume: 68
  start-page: 50
  year: 2015
  ident: 106_CR24
  publication-title: Jpn. J. Infect. Dis.
  doi: 10.7883/yoken.JJID.2014.051
– volume: 16
  start-page: 880
  year: 2015
  ident: 106_CR28
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3213
– volume: 214
  start-page: 309
  year: 2017
  ident: 106_CR32
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20161590
– volume: 145
  start-page: 59
  year: 1985
  ident: 106_CR20
  publication-title: Carbohydr. Res.
  doi: 10.1016/S0008-6215(00)90412-9
– volume: 127
  start-page: 1491
  year: 2017
  ident: 106_CR26
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI91192
– volume: 422
  start-page: 102
  year: 2015
  ident: 106_CR40
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2015.04.010
– volume: 12
  start-page: 367
  year: 1955
  ident: 106_CR3
  publication-title: J. Gen. Microbiol.
  doi: 10.1099/00221287-12-2-367
– volume: 7
  year: 2017
  ident: 106_CR18
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-06682-2
– volume: 2
  start-page: 1
  year: 2009
  ident: 106_CR49
  publication-title: R package version
– volume: 6
  start-page: 122
  year: 2013
  ident: 106_CR29
  publication-title: Mucosal Immunol.
  doi: 10.1038/mi.2012.56
– volume: 43
  start-page: 120
  year: 2015
  ident: 106_CR30
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.06.013
– volume: 306
  start-page: 89
  year: 2016
  ident: 106_CR16
  publication-title: Int. J. Med. Microbiol.
  doi: 10.1016/j.ijmm.2015.12.002
– volume: 17
  year: 2016
  ident: 106_CR48
  publication-title: BMC Bioinformatics
  doi: 10.1186/s12859-016-0920-1
– volume: 44
  start-page: 683
  year: 1926
  ident: 106_CR1
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.44.5.683
– volume: 180
  start-page: 3735
  year: 1998
  ident: 106_CR21
  publication-title: J. Bacteriol.
  doi: 10.1128/JB.180.15.3735-3740.1998
– volume: 36
  start-page: 460
  year: 2015
  ident: 106_CR33
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2015.06.006
– volume: 45
  start-page: 2698
  year: 2015
  ident: 106_CR39
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201545526
– volume: 329
  start-page: 112
  year: 2008
  ident: 106_CR38
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2007.09.017
– volume: 104
  start-page: 7528
  year: 2007
  ident: 106_CR43
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0700630104
– volume: 37
  start-page: 56
  year: 1999
  ident: 106_CR7
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.37.1.56-62.1999
– volume: 8
  start-page: 684
  year: 2017
  ident: 106_CR17
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2017.00684
– volume: 57
  start-page: 571
  year: 1933
  ident: 106_CR2
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.57.4.571
– volume: 282
  start-page: 4679
  year: 2015
  ident: 106_CR22
  publication-title: FEBS J.
  doi: 10.1111/febs.13530
– volume: 13
  year: 2012
  ident: 106_CR45
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-13-31
– volume: 30
  start-page: 2811
  year: 2014
  ident: 106_CR51
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu393
– volume: 16
  start-page: 215
  year: 2014
  ident: 106_CR23
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2014.07.003
– volume: 195
  start-page: 383
  year: 2002
  ident: 106_CR14
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20011112
– volume: 47
  start-page: 118
  year: 2017
  ident: 106_CR12
  publication-title: Immunity
  doi: 10.1016/j.immuni.2017.06.013
– volume: 16
  start-page: 767
  year: 2016
  ident: 106_CR10
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri.2016.114
– volume-title: ggplot2: Elegant Graphics for Data Analysis
  year: 2009
  ident: 106_CR50
  doi: 10.1007/978-0-387-98141-3
– volume: 458
  start-page: 1191
  year: 2009
  ident: 106_CR19
  publication-title: Nature
  doi: 10.1038/nature07830
– volume: 121
  start-page: 1946
  year: 2011
  ident: 106_CR37
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI44447
– volume: 1
  start-page: 51
  year: 2007
  ident: 106_CR25
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2007.01.002
– volume: 4
  start-page: 550
  year: 1997
  ident: 106_CR6
  publication-title: Clin. Diagn. Lab. Immunol.
  doi: 10.1128/CDLI.4.5.550-555.1997
– volume: 7
  start-page: 335
  year: 2010
  ident: 106_CR46
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.f.303
– volume: 16
  start-page: 1761
  year: 1998
  ident: 106_CR34
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(98)00139-X
– reference: 29777208 - Nat Immunol. 2018 Jun;19(6):514-515
SSID ssj0014764
Score 2.5664315
Snippet Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 617
SubjectTerms 631/250/2152/2153/1291
631/250/2499
631/250/347
Antibiotic resistance
Antibodies
Antigenic determinants
Antigens
B cells
Bacterial diseases
Bacterial infections
Biomedical and Life Sciences
Biomedicine
Drug therapy
Epitopes
Immune response
Immune response (humoral)
Immunoglobulin A
Immunoglobulin M
Immunoglobulins
Immunological memory
Immunology
Infection
Infection control
Infectious Diseases
Intestine
Klebsiella infections
Klebsiella pneumoniae
Lipopolysaccharides
Lymphocytes B
Memory cells
Microbial drug resistance
Microbial polysaccharides
Microbiota
Microbiota (Symbiotic organisms)
Microorganisms
Mitogens
Monoclonal antibodies
Nosocomial infection
O antigens
Opportunist infection
Pathogenic microorganisms
Pathogens
Peripheral blood
Pneumonia
Polysaccharides
Prevention
Risk factors
Serotypes
Surface antigens
T cells
Title Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen
URI https://link.springer.com/article/10.1038/s41590-018-0106-2
https://www.ncbi.nlm.nih.gov/pubmed/29760533
https://www.proquest.com/docview/2042728696
https://www.proquest.com/docview/2039289995
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9wwDBdby8ZextZ9ZeuKNwaDjbDEjmP7aXRHS_fRrrQr3MPAOIlTDkpybe4e9t9PSpzrrrC-BI4oyVmWrJ8sWQJ4V0vujcxKVHHpYrTQqFLCi1gXrspzzeuy37o4PMoPzrJvUzkNG25dSKsc18R-oa7akvbI0UnPuOI6N_nn-WVMXaMouhpaaNyFTSpdRlKtpiuHK81UXz4KTZSJuUn0GNUU-lOHhstQShalcqFTzdfs0s3V-R_zdCNe2puh_UfwMOBHtjtM-GO445stuDd0lPyzBfcPQ6z8Cfye0IdiOkpJ6UCItllbs1CXAdc41rfnY8jZWdFSLiFz526GaJF9v_BFN6O0KDZv_BJHPnOe_Tg-ZT9jIkeZewpn-3u_Jgdx6KUQl1KYRaxEphAqGY-IJKkyRbgwRTCmlSiczxH51I6OXxVGpCJHikobRA6ikmmNfOTiGWw0beNfAHPo13rPEyldju5VbbQqtXL4A92PokwiSEZO2jIUGqd-Fxe2D3gLbQfmW2S-JeZbHsGH1SPzocrGbcRvaXosVa9oKD3m3C27zn49PbG7UqGLpDKTR_A-ENUtfrx04bQBDoEKXq1Rbq9RonqV67dHKbBBvTt7LYwRvFndpidpbhrfLokGoSd6s0ZG8HyQntXYOIJAOgQdwcdRnK5f_t-Bv7z9r7yCB7yXZ9oi2oaNxdXSv0bEtCh2erXAq56kO7D5Ze_o-OQvx9YNlA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw9Gga4vKCYNwCAwwCITFFpHYc2w8ITYWppe1AbJP2gGSc1JkqTUkhrdB-im_knFw6Oom97bHySVIfn6vPDeBVLrk3Ms6QxaULUUMjSwkvQp26aZJonmf11cVkPxkcxZ-P5fEG_OlqYSitspOJtaCelhndkaOTHnPFdWKSD_OfIU2NouhqN0KjIYuRP_uNLlv1fvgRz_c153ufDvuDsJ0qEGZSmEWoRKzQaDAedXM0jRVZSD00S7QSqfMJ2gC5o0Kk1IieSBBiqg3qUDGVvbwXK2p0gCL_WiyQNakyvb9KKcHVul0VqkQTchPpLooq9LsKFaWhFDBKHUMnnq_pwYva4B91eCE-W6u9vTtwu7VX2W5DYHdhwxdbcL2ZYHm2BTcmbWz-Hnzv04dCKt2k9CO07lmZs7YPBMpUVo8DZHiSs7Sk3EXmTtwMrVM2OvVpNaM0LDYv_BIxPXOejb8esC8hgSON34ejK8HyA9gsysI_AubQj_aeR1K6BN253GiVaeXwB7o7aRYFEHWYtFnb2Jzma5zaOsAutG2QbxH5lpBveQBvV4_Mm64elwG_pOOx1C2joHScE7esKjs8-GZ3pUKXTMUmCeBNC5SX-PHMtdUNuAVqsLUGub0GieycrS93VGBbcVLZc-IP4MVqmZ6ksyl8uSQYNHXRezYygIcN9az2xtHopKLrAHY6cjp_-X83_vjyv_Icbg4OJ2M7Hu6PnsAtXtM2XU9tw-bi19I_RWttkT6rWYTBj6vmyb9OVkNA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1da9RAcCgViy9S61ds1VUUQQnN7Wazuw8i5erR89parIU-FNZNblMOSnKaO6R_zV_nTD6uXsG-9fHYSXI7O587XwBvcsm9kXGGLC5diBoaWUp4EerUjZNE8zyrry4ODpO9k_jLqTxdgT9dLQylVXYysRbU4zKjO3J00mOuuE5Msp23aRFHu4NP058hTZCiSGs3TqMhkZG__I3uW_VxuItn_Zbzwefv_b2wnTAQZlKYWahErNCAMB71dDSOFVlLPTRRtBKp8wnaA7mjoqTUiJ5IEGKsDepTMZa9vBcranqA4v-OEkoTj-n-Ir0EV-vWVageTchNpLuIqtDbFSpNQ-lglEaGDj1f0onXNcM_qvFarLZWgYN1uN_armynIbYHsOKLDbjbTLO83IC1gzZO_xDO-vShkMo4KRUJLX1W5qztCYHyldWjARme6iQtKY-RuXM3QUuVjS58Wk0oJYtNCz9HTE-cZ_tHx-xrSOBI74_g5Faw_BhWi7LwT4E59Km955GULkHXLjdaZVo5_IGuT5pFAUQdJm3WNjmnWRsXtg62C20b5FtEviXkWx7A-8Uj06bDx03Ar-l4LHXOKIgGz928quzw-JvdkQrdMxWbJIB3LVBe4scz11Y64Bao2dYS5NYSJLJ2trzcUYFtRUtlrxghgFeLZXqSzqbw5Zxg0OxFT9rIAJ401LPYG0cDlAqwA_jQkdPVy_-78Wc3_5WXsIbcaPeHh6NNuMdr0qabqi1Ynf2a--douM3SFzWHMPhx2yz5Fw8_R3Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cross-specificity+of+protective+human+antibodies+against+Klebsiella+pneumoniae+LPS+O-antigen&rft.jtitle=Nature+immunology&rft.au=Rollenske%2C+Tim&rft.au=Szijarto%2C+Valeria&rft.au=Lukasiewicz%2C+Jolanta&rft.au=Guachalla%2C+Luis+M.&rft.date=2018-06-01&rft.pub=Nature+Publishing+Group+US&rft.issn=1529-2908&rft.eissn=1529-2916&rft.volume=19&rft.issue=6&rft.spage=617&rft.epage=624&rft_id=info:doi/10.1038%2Fs41590-018-0106-2&rft.externalDocID=10_1038_s41590_018_0106_2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1529-2908&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1529-2908&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1529-2908&client=summon